The study, led by Xingyu Liu and Yue Zheng under the supervision of Jie Luo and Qing Fan, was prospectively preregistered at ClinicalTrials.gov under identifier NCT05020301, meaning the researchers specified their outcome measures before analyzing the data. Forty adults participated: twenty experienced meditators and twenty novices. Each participant underwent resting-state functional magnetic resonance imaging under two conditions, once with eyes open and once with eyes closed. Resting-state fMRI measures spontaneous fluctuations in blood oxygenation, an indirect proxy for neural activity, while the participant performs no explicit task. The researchers chose this approach deliberately. Trait mindfulness, the dispositional tendency to attend to present-moment experience with acceptance, is not something that switches on only during formal meditation; the question was whether its neural fingerprints would appear even during ordinary wakeful rest.

To decompose the imaging data, the team used independent component analysis, a data-driven method that separates the four-dimensional fMRI signal into spatially distinct components whose time courses covary. Group independent component analysis, first formalized by Calhoun and colleagues in 2001, allows researchers to identify intrinsic connectivity networks that are consistent across participants, such as the default mode network, the frontoparietal control network, and the salience network. These large-scale networks are central to modern accounts of cognition and psychopathology: the default mode network is associated with self-referential thought and mind-wandering, the frontoparietal network with executive control and flexible attention, and the salience network with switching between internal and external orientation. Mindfulness, on this framework, can be understood as a shift in the balance of power among these networks, weakening the grip of self-focused rumination while strengthening attentional control.

The static analysis averaged connectivity across the entire scan, yielding a single estimate of how strongly each pair of networks communicated. Here the meditators stood out in one specific relationship: connectivity between the left frontoparietal network and the anterior default mode network was stronger in experienced meditators than in novices. Intriguingly, this effect was tied to the eyes-closed condition, and the strength of this specific connection correlated positively with scores on the Acting with Awareness subscale of the Five Facet Mindfulness Questionnaire, a widely used self-report instrument developed by Baer and colleagues that decomposes mindfulness into five facets including observing, describing, nonjudging, nonreactivity, and acting with awareness. Acting with Awareness reflects the tendency to bring full attention to current activity rather than operating on autopilot, and the finding suggests that the link between executive control circuitry and self-referential circuitry may be a neural substrate of that capacity.

The dynamic analysis went further. Rather than averaging, the researchers used a sliding-window approach, computing connectivity within short temporal windows and clustering the resulting windowed connectivity matrices into recurring brain states. This methodology, pioneered by Allen, Damaraju, Calhoun and colleagues, treats the brain as a system that wanders through a small repertoire of metastable configurations rather than holding a single steady state. Each configuration, or state, can be characterized by the overall pattern of inter-network connectivity, and each participant can be described by how much time they spend in each state, the so-called dwell time, and how often they transition between states. Critics have noted that some apparent connectivity dynamics can be artifacts of head motion or noise, but the framework has been increasingly validated and is now applied widely in studies of development, depression, and meditation.

The dynamic results were arguably the most striking. Experienced meditators spent longer periods of time in a highly integrated network state, one in which the major large-scale networks are strongly coupled with one another, and shorter periods in a partially segregated state in which networks decouple into more independent modules. Both measures, longer dwell time in the integrated state and shorter dwell time in the segregated state, correlated with Acting with Awareness scores, paralleling the static finding and suggesting that the same mindfulness facet is reflected at multiple temporal scales. The pattern fits a growing view in the literature that mental health and cognitive flexibility are associated not with maximal stability of brain dynamics, but with an optimal balance: the ability to sustain coherent whole-brain coordination while retaining the capacity to shift configurations when circumstances demand. Prior work by Lim, Teng, Patanaik, Tandi and Massar had reported dynamic connectivity markers of trait mindfulness, and Treves and colleagues found similar dynamic correlates in adolescents, lending convergent support to the idea that mindfulness traits are encoded in temporal flexibility rather than fixed wiring alone.

To determine whether these connectivity features could actually distinguish meditators from novices, the researchers turned to Bayesian logistic regression with cross-validation, a classification approach that produces probabilistic predictions and handles uncertainty in a principled way. The models achieved respectable discriminative performance, with an accuracy of 0.73 and an area under the receiver operating characteristic curve of 0.81 when using static functional network connectivity features. Notably, adding dynamic connectivity features and FFMQ questionnaire scores did not meaningfully improve performance beyond the static features alone. This is a nuanced result. On one hand, it establishes that whole-brain connectivity contains a usable, quantifiable signature of meditation experience, a step toward the kind of brain-based biomarkers that have been pursued in psychiatry more broadly. On the other hand, it indicates that the static signal carried most of the discriminative information in this sample, and that the dynamic measures, while theoretically informative and correlated with behavior, did not add incremental predictive power under the study’s conditions.

Several factors may explain this. The sample size of forty is modest by machine learning standards, and dynamic connectivity measures are inherently noisier, requiring longer scans to estimate reliably. The sliding-window approach has well-documented trade-offs between temporal resolution and statistical stability. It is also possible that dynamic features and self-report measures are partially redundant with the static features they derive from, so their addition cannot rescue classification when the underlying static signal already captures the between-group difference. The authors are careful not to overclaim; their stated conclusion is that static and dynamic connectivity make distinct contributions to understanding the neural correlates of mindfulness, and that connectivity-based markers hold potential for characterizing mindfulness-related traits and informing individualized interventions.

The findings arrive amid intense interest in mindfulness as an intervention. Meta-analyses, including work by Khoury and colleagues and the individual-participant-data meta-analysis by Galante and colleagues published in Nature Mental Health, support modest but reliable benefits of mindfulness-based programs for mental health in non-clinical populations, and neuroimaging studies have linked training to changes in default mode, salience, and central executive network connectivity, reduced inflammatory markers such as interleukin-6, and improved network reconfiguration efficiency. What most of this work shares is a static view of the brain. By showing that trait mindfulness is also associated with how long the brain remains in integrated versus segregated states, the new study adds a temporal dimension to the mechanistic account, one that could eventually help explain why some people respond to mindfulness training while others do not.

There are, of course, limits to interpretation. This was a cross-sectional comparison between experienced meditators and novices, not a randomized trial, so the differences could partly reflect pre-existing traits that drew people to meditation in the first place, or lifestyle factors correlated with long-term practice. The eyes-open versus eyes-closed manipulation also matters, since prior work by Agcaoglu and colleagues has shown that resting-state connectivity differs systematically between these conditions, and the meditation-related effect here emerged specifically with eyes closed. Self-report measures, however well validated, remain subjective. And because connectivity signatures were derived from group independent component analysis, individual variability in network definition can influence results.

Still, the study exemplifies a broader shift in cognitive neuroscience: away from static maps and toward the chronnectome, the time-varying landscape of brain connectivity, and toward combining rich feature sets with principled statistical learning. For the growing community studying contemplative practices, the message is that flexibility, not just stability, characterizes the mindful brain. For clinicians and intervention designers, the prospect of connectivity-based markers that track an individual’s mindfulness-related traits opens a path toward personalized assessment, perhaps one day allowing practitioners to measure, rather than merely ask about, the neural changes that meditation is intended to cultivate. The datasets analyzed in the study are not publicly available due to institutional ethics requirements, but the preregistration and analysis framework offer a template for replication as dynamic connectivity methods mature.

Spinal cord injuries have long posed a formidable barrier to restoring motor and sensory function due to the central nervous system’s inherently limited regenerative capacity. Following a traumatic injury, the formation of a glial scar and the presence of inhibitory molecules such as Nogo-A impede axonal outgrowth and neural network reorganization. The Anti-Nogo-A NG101 treatment operates by neutralizing Nogo-A, a myelin-associated inhibitor that significantly constrains neural regeneration. By blocking this molecule, the therapy enables previously suppressed neural pathways to reorganize, fostering regrowth across the damaged spinal segments.

The research team, led by Farner, Scheuren, and Sharifi, employed cutting-edge neuroimaging and histological techniques to assess micro- and macrostructural changes within the spinal cord post-treatment. Their methodological rigor spanned advanced diffusion tensor imaging (DTI) to trace axonal integrity and high-resolution confocal microscopy for cellular-level examination. The results demonstrated a marked improvement in white matter integrity and an increase in axonal sprouting, illustrating the multifaceted nature of the therapeutic effects induced by Anti-Nogo-A NG101.

Notably, the study’s experimental design involved a controlled application of Anti-Nogo-A NG101 following standardized spinal cord injury in animal models, ensuring reproducibility and precise evaluation of treatment efficacy. Behavioral assays complemented the structural analyses, revealing substantial recoveries in motor function that were directly correlated with the observed neuroanatomical improvements. These findings underscore the translational potential of Anti-Nogo-A NG101, hinting at future clinical trials aimed at human subjects.

One of the most striking revelations from the study was the dual scale of neural repair facilitated by Anti-Nogo-A NG101. At the microstructural level, there was pronounced remyelination and normalization of axonal morphology, which are critical for restoring electrical conductivity and neural signaling fidelity. On the macrostructural front, the spinal cord exhibited diminished lesion volume and enhanced tissue sparing, indicating a broader scope of neuroprotection that extends beyond mere axonal regrowth.

The molecular underpinnings of Anti-Nogo-A’s mechanism indicate that neutralizing Nogo-A alleviates the inhibitory milieu characteristic of the post-injury environment, thereby reactivating intrinsic growth programs within neurons. This therapeutic reengagement of regenerative cascades potentially reboots developmental pathways, which are otherwise dormant in adult neurons. By effectively modulating this biochemical landscape, NG101 catalyzes a paradigm shift from neurodegeneration toward regeneration.

Furthermore, the longitudinal monitoring of treatment effects revealed sustained benefits over extended periods, suggesting that Anti-Nogo-A NG101 offers not only immediate reparative advantages but also long-term stabilization of neural circuits. This durability is essential for chronic SCI patients, wherein secondary degenerative processes typically exacerbate functional decline. The intervention’s ability to confer prolonged neuroprotection opens new frontiers for managing both acute and chronic phases of spinal injury.

Importantly, the study also highlights the interplay between neuroinflammation and regenerative processes in the context of Anti-Nogo-A therapy. By attenuating Nogo-A signaling, there appears to be a concomitant modulation of inflammatory responses that otherwise contribute to secondary tissue damage. This dual anti-inflammatory and pro-regenerative action positions NG101 as a multifaceted therapeutic agent capable of addressing the complex pathology of SCI.

The implications of these findings resonate well beyond SCI, providing a conceptual framework for tackling other central nervous system disorders marked by inhibitory molecular environments, such as stroke and multiple sclerosis. By targeting molecular inhibitors like Nogo-A, researchers envision broader applications of this strategy to enhance neural plasticity and functional recovery in a variety of neurological conditions.

This study also paves the way for innovative drug delivery modalities designed to optimize the spatial and temporal targeting of NG101. Future research directions include refining administration protocols and exploring synergistic effects with rehabilitation therapies or bioengineering approaches like neural scaffolds. Such integrative strategies could amplify regenerative outcomes and accelerate translation to clinical practice.

Moreover, the work presents a compelling example of bench-to-bedside translational science, emphasizing the importance of comprehensive preclinical evaluation in shaping effective interventions. The meticulous characterization of both structural and functional recovery metrics ensures that therapeutic claims are robust and clinically relevant.

The enthusiasm generated by Anti-Nogo-A NG101’s efficacy also fuels discourse on ethical and regulatory frameworks necessary to expedite human trials while ensuring patient safety. The translational pathway from animal models to human application requires concerted collaborative efforts spanning neuroscientists, clinicians, and policy-makers to harness the therapy’s full potential.

Ultimately, this research signifies a beacon of hope within the spinal cord injury field, historically fraught with therapeutic frustration. The capacity to induce reparative micro- and macrostructural changes not only enhances the prospects for physical rehabilitation but also rejuvenates patient optimism for meaningful recovery and improved quality of life.

In essence, the novel Anti-Nogo-A NG101 treatment transcends existing SCI therapies by fundamentally altering the biological constraints that have impeded neural repair. Future efforts will undoubtedly build upon these transformative insights to craft next-generation interventions that seamlessly integrate molecular modulation with regenerative medicine.

As this revolutionary approach gains traction, it may redefine therapeutic paradigms and establish a new standard of care for spinal cord injuries, marking a historic milestone in neuroscience and clinical rehabilitation.

Subject of Research: The study focuses on the effects of Anti-Nogo-A NG101 treatment on spinal cord micro- and macrostructural changes following spinal cord injury.

Article Title: Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injury.

Article References: Farner, L., Scheuren, P.S., Sharifi, K. et al. Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injury. Nat Commun 17, 4197 (2026). https://doi.org/10.1038/s41467-026-71412-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-026-71412-0